From this month the Transplant Library includes invited commentaries by transplantation experts. The commentary includes a clinical impact rating and also indicates whether the trial is considered practice changing.
The randomised controlled trial “De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial” by Asrani and colleagues is considered practice changing by our expert and received a 5/5 clinical impact rating score.
You can read the full commentary in the Transplant Library. Get a trial account today!